Pharma Marketing News
News & Views for
Responsible Marketers


Messages from Our Sponsors

Pharma Glossary


Pharmaguy's Picks



Pharma Marketing Network Curated Content Forums
The Leading Online Source of Curated Content for Pharmaceutical Marketing Experts
Newsletter | Conferences | Podcasts | Glossary | Surveys | Blog | Advertising Information | Contact Us


"Must Read Blog for Insiders." -- Wall Street Journal
Pharma Marketing News
Current Issue of Pharma Marketing News Available!

Search the Entire Pharma Marketing Forums Site

Go Back   Pharma Marketing Network Curated Content > News & Views > Industry News

Industry News Pharmaceutical industry news from newsfeeds, press releases, news stories, etc.

Reply
 
Thread Tools Rate Thread Display Modes
  #1  
Old 21st July 2009, 10:17 AM
Pharma Newshound Pharma Newshound is offline
News Gatherer
 
Join Date: Dec 2007
Location: USA
Posts: 11,044
Default GAO: FDA Can't Determine How Much Money It Needs

Source: WSJ

2nd UPDATE: GAO: FDA Can't Determine How Much Money It Needs

By Jennifer Corbett Dooren
Of DOW JONES NEWSWIRES

WASHINGTON (Dow Jones)--The Food and Drug Administration isn't able to reliably determine how much money it needs to regulate medical products because, among other things, its staff can't track all the adverse-event reports it handles, according to the Government Accountability Office.

According to a GAO report released Monday, the government watchdog noted that while FDA's funding has increased since 2004, so has the agency's responsibilities.

GAO first raised concerns about FDA's inability to determine how much money it really needs to do its job in a previous report 20 years ago. Congressional lawmakers in both parties have raised concerns about whether FDA has enough money to oversee a growing and increasingly complex array of medical products.

The GAO looked at agency funding and workload from fiscal years 2004 to 2008 in the agency's drug, devices and vaccines and biologics division.

GAO said while the number of adverse-event reports - which help the agency track drug and medical-device safety problems - increased during that time, FDA officials couldn't provide data about how many reports it reviewed, for example.

"Without such information, FDA cannot develop complete and reliable estimates of its resources needs," GAO said.

GAO said the FDA received 522,871 drug-related adverse-event reports in 2008 compared with 426,016 in 2004. Device reports jumped to 588,161 from 189,450 while reports involving biologics also showed large gains. FDA told GAO while they place a priority on reviewing serious adverse-event reports, they receive "substantially" more adverse-event reports than staff can review. The FDA said the adverse-event reporting systems don't allow agency to track whether individual reports have been reviewed.

In a letter to GAO, FDA's principal deputy commissioner, Joshua Sharfstein, said the agency agrees with the need to track staffing and work product to help form budget requests and is putting such systems in place. Of the approximately $2.2 billion FDA annual budget, about $1.7 billion comes from Congress while the rest is collected from drug and medical device makers through user fees.

GAO said the bulk of FDA's funding increase from 2004 to 2008 came from user fees rather than Congress. The additional money was put toward reviews of medical products where the agency was generally able to keep up with statutory time frames for approving products. FDA is required to allocate user fees to medical product reviews, although in 2007 the law was changed to allow the agency to spend some of that money to track safety of approved products.

FDA officials have conceded that other areas not funded by user fees, such as inspections and the review and approval of generic drug applications, fell behind from 2004 to 2008.

Congress approved a $100 million funding increase for FDA in 2009 and the Obama administration has asked for a $240 million increase for the upcoming 2010 fiscal year.

-By Jennifer Corbett Dooren, Dow Jones Newswires; 202-862-9294; jennifer.corbett@dowjones.com
__________________
Pharma Newshound
"I sift through the news so you don't have to!"


Please take the PMN Forums Visitor Survey and help us provide a better experience. It will only take 1 minute of your time.

Got news? Tell me about it:
newshound@forums.pharma-mkting.com
Reply With Quote
Reply


Thread Tools
Display Modes Rate This Thread
Rate This Thread:

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is On
Forum Jump


All times are GMT -5. The time now is 01:25 PM.


Powered by vBulletin® Version 3.6.4
Copyright ©2000 - 2014, Jelsoft Enterprises Ltd.
(c) 2014, Pharma Marketing Network. All rights reserved.